Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
Status: | Completed |
---|---|
Conditions: | Cosmetic, Dermatology, Dermatology, Hair Loss |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | Any |
Updated: | 11/18/2012 |
Start Date: | June 2010 |
End Date: | November 2012 |
Contact: | Allergan Inc. |
Email: | clinicaltrials@allergan.com |
This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily
application to the upper eyelid margins compared with vehicle in treating eyelash loss or
hypotrichosis (inadequate or not enough eyelashes) in children
Inclusion Criteria:
- Children who have inadequate eyelashes or have lost their eyelashes as a result of
chemotherapy treatment, who completed their chemotherapy (intensive treatment) at
least 4 weeks before starting the study, are considered to be at low risk for relapse
of their cancer, and are well enough to complete the study
- Children who have minimal to moderate inadequate eyelashes due to alopecia areata
- Adolescents between the ages of 15-17 years who have minimal to marked inadequate
eyelashes
Exclusion Criteria:
- Any eye disease or abnormality, eye surgery, permanent eyeliner, eyelash implants.
- Semi-permanent eyelash tint, dye or eyelash extension application within 3 months
- Use of over the counter eyelash growth products within 6 months.
- Use of prescription eyelash growth products (eg, Latisse®)
- Any eye condition that would prevent required ophthalmology exams
We found this trial at
1
site
Click here to add this to my saved trials